Today: 7 February 2026
Subscribe
Browse Category

NYSE:ZTS News 4 November 2025 - 26 December 2025

Zoetis (ZTS) Stock: What to Know Before the Market Opens on Dec. 26, 2025

Zoetis (ZTS) Stock: What to Know Before the Market Opens on Dec. 26, 2025

U.S. stocks return from the Christmas holiday pause with Zoetis Inc. (NYSE: ZTS) back in focus—not because of an earnings report due today, but because December has brought a cluster of shareholder-return actions, product catalysts, and analyst resets that investors are still digesting heading into the next session. Keep one calendar detail in mind first: U.S. exchanges were closed on Thursday, Dec. 25 (Christmas Day), and Wednesday, Dec. 24 had an early close at 1:00 p.m. ET. That means many investors are coming into Friday’s session with fewer “fresh” price signals than usual, making recent headlines and forward expectations matter
26 December 2025
·
Zoetis Stock (ZTS) After Hours on Dec. 24, 2025: Price Action, Today’s Headlines, Analyst Forecasts, and What to Watch Before the Next Market Open

Zoetis Stock (ZTS) After Hours on Dec. 24, 2025: Price Action, Today’s Headlines, Analyst Forecasts, and What to Watch Before the Next Market Open

Zoetis Inc. (NYSE: ZTS) wrapped up the Christmas Eve, holiday-shortened session with a solid gain—and then held steady in thin after-hours trading as investors headed into the U.S. market’s Christmas Day shutdown. After the bell on Wednesday, Dec. 24, 2025, ZTS was changing hands around $125.50 in extended trading, essentially flat after-hours, following a session that ended up about +1.6% on the day. MarketBeat+1 Before diving into the headlines and forecasts, one important calendar note: U.S. stock markets are closed Thursday, Dec. 25 (Christmas Day). The next opportunity for U.S. equity trading is Friday, Dec. 26 (a normal session). New
25 December 2025
·
Zoetis Stock (ZTS) News Today: $1.75B Convertible Notes, Accelerated Buybacks, Dividend Raise, and Analyst Forecasts (Dec. 17, 2025)

Zoetis Stock (ZTS) News Today: $1.75B Convertible Notes, Accelerated Buybacks, Dividend Raise, and Analyst Forecasts (Dec. 17, 2025)

Zoetis Inc. (NYSE: ZTS) stock is back in focus on Wednesday, December 17, 2025, as investors weigh a fresh analyst update against a flurry of recent corporate actions—most notably a $1.75 billion convertible notes financing designed to fund substantial share repurchases, plus a dividend increase heading into 2026. MarketScreener+2investor.zoetis.com+2 Zoetis is the world’s largest pure-play animal health company, with a portfolio spanning companion animal and livestock medicines, vaccines, diagnostics, and technology. Business Wire+1 What’s moving Zoetis stock on Dec. 17, 2025? Two themes are dominating today’s conversation around ZTS stock: From a tape-reading standpoint, Zoetis stock has been trading around
17 December 2025
··
Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Company Overview & 2025 Developments Zoetis is the global frontrunner in animal health, offering a diverse portfolio for both companion animals (pets) and farm animals. The company’s products range from vaccines and parasiticides to dermatology treatments and high-tech diagnostics. This breadth has helped Zoetis capture the #1 industry position – in 2023 its $8.5B in sales exceeded the next-largest competitor by over 50%proclinical.comproclinical.com. Zoetis continues to leverage this scale and innovation engine in 2025, focusing on pet care growth while managing challenges in livestock. Recent 2025 highlights: The first half of 2025 saw Zoetis deliver solid growth. In Q1, revenue
4 November 2025
··

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop